| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/13/2004 | CA2155020C Antiviral naphthoquinone compounds, compositions and uses thereof |
| 07/13/2004 | CA2047699C Expanded porphyrins: large prophyrin-like tripyrroledimethine-derived macrocycles |
| 07/08/2004 | WO2004057011A1 Antibiotics caprazamycins d, g, d1 and g1 and process for producing the same |
| 07/08/2004 | WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | WO2004056876A1 Polypeptides with antiviral activity |
| 07/08/2004 | WO2004056871A2 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | WO2004056843A2 10-substituted macrolide antibiotics |
| 07/08/2004 | WO2004056828A2 Novel compounds and uses thereof |
| 07/08/2004 | WO2004056818A1 Oxazolidinone derivatives as antibacterial |
| 07/08/2004 | WO2004056816A1 Antibacterial oxazolidinones |
| 07/08/2004 | WO2004056770A2 Piperidine derivatives useful as ccr5 antagonists |
| 07/08/2004 | WO2004056764A1 Aromatic derivatives as hiv aspartyl protease inhibitors |
| 07/08/2004 | WO2004056747A1 Dhodh-inhibitors and method for their identification |
| 07/08/2004 | WO2004056746A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004056391A1 A method of immunisation and agents useful for same |
| 07/08/2004 | WO2004056390A1 Trivalent vaccine with maternal antibody transfer via the milk |
| 07/08/2004 | WO2004056380A2 Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004056374A1 Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients |
| 07/08/2004 | WO2004056349A2 Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents |
| 07/08/2004 | WO2004056322A2 Antibiotics containing borinic acid complexes and methods of use |
| 07/08/2004 | WO2004043435A3 Systemic delivery of antiviral agents |
| 07/08/2004 | WO2004039822A3 4’’ - modified erythromycin derivatives |
| 07/08/2004 | WO2004039377A8 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004012653A3 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003101399A3 Novel bacterium for treatment of disease |
| 07/08/2004 | WO2003079757A3 Hiv therapeutic |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003059193A8 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 07/08/2004 | WO2003058021A3 Novel apoptosis-inducing dna sequences |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | WO2002034203A3 Novel derivatives of phenyl 4-aminosalicylate and method of making the same |
| 07/08/2004 | WO2001022916A3 Novel hev antigenic peptide and methods |
| 07/08/2004 | US20040133001 Peptide deformylase inhibitors |
| 07/08/2004 | US20040132994 For therapy of of infectious diseases |
| 07/08/2004 | US20040132993 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 07/08/2004 | US20040132992 Process for the selective preparation of 3-(z) propenyl-cephem compound |
| 07/08/2004 | US20040132979 Using chromatographic support to isolate and enhance fluid fraction for therapeutic immunoglobulins; vaccines; immunotherapy |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132805 preferably also contains a compound that donates, transfers, releases or induces production of nitric oxide and a hydralazine antioxidant; for treating and/or preventing a vascular disease characterized by nitric oxide insufficiency |
| 07/08/2004 | US20040132791 N-(on SO2 ) (2-hydroxy-3-substituted aminopropyl)-substituted; inhibiting retroviral replication |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132778 Method for treating retroviral infections |
| 07/08/2004 | US20040132756 incorporating tartaric acid in a solid preparation having a high content of a quinolone compound, particularly sitafloxacin; reduced in fluctuations of oral absorption |
| 07/08/2004 | US20040132748 Novel adenne derivatives |
| 07/08/2004 | US20040132740 structurally related to compounds such as ciprofloxacin but without the carboxylic acid or ester functionality, are not only also highly effective as antibiotics, but show a superior antibacterial effect. |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/08/2004 | US20040132723 e.g., 9-Ethyl-3-methyl-12-{2-{(1,2,3,4-tetrahydro-1-oxo-5-isoquinolinyl)oxy}ethyl}-9H-imidazo[1,2-d]dipyrido[2,3-b:3',2'-f][1,4]diazepine; potent inhibitors of wild-type (WT) and double mutant strains of HIV-1 RT |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132711 Treatment of Human Immunodeficiency Virus, organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis. |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | US20040132709 Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates |
| 07/08/2004 | US20040132707 Bactericides, especially gramnegative bacteria; side effect reduction |
| 07/08/2004 | US20040132700 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial madrix adhesion such as asthma cystic fibrosis and influenza |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132684 Modified oligonucleotides or polynucleotides, with modified pyrimidine base, modified purine base, modified ribose, phosphonate linkages, or phosphorothioate linkages; viral infections, cancer, microbial infection; sustained release |
| 07/08/2004 | US20040132676 Polynucleotide formulation for enhanced intracellular transfer |
| 07/08/2004 | US20040132673 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 07/08/2004 | US20040132652 Liposome associated to Neisseria meningitis polypeptide fragments or DNA fragments; prevention or diagnosis of infection |
| 07/08/2004 | US20040132641 Fas peptide mimetics and uses thereof |
| 07/08/2004 | US20040132185 Cd8alphadendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 07/08/2004 | US20040132179 Treatment of t cell disorders |
| 07/08/2004 | US20040132164 Methods and compositions for inhibiting adhesion by microorganisms |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132140 comprises using a cell resistant to a lectin which recognizes a sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine in the reducing end through alpha -bond in a complex N-glycoside-linked sugar chain |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132088 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 07/08/2004 | US20040132057 Tumor necrosis related receptor,TR7 |
| 07/08/2004 | US20040132053 Sphingosine kinase enzyme |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040132028 Collection of repeat proteins comprising repeat modules |
| 07/08/2004 | US20040132014 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 07/08/2004 | US20040132012 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131702 Mixture with acid |
| 07/08/2004 | US20040131701 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs |
| 07/08/2004 | US20040131650 Mixture containing viral, bacteria, parasitic antigen |
| 07/08/2004 | US20040131642 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof |
| 07/08/2004 | US20040131641 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 07/08/2004 | US20040131639 Novel recombinant tryptophan mutants of influenza |
| 07/08/2004 | US20040131638 Novel composition |
| 07/08/2004 | US20040131634 Neisseria lactoferrin binding protein |
| 07/08/2004 | US20040131630 Administering a attenuated bacteria ; nucleic acids; induce immunology response |
| 07/08/2004 | US20040131625 Vaccine composition |
| 07/08/2004 | US20040131620 Human polyclonal antibody compositions |
| 07/08/2004 | US20040131609 Ultra high affinity neutralizing antibodies |
| 07/08/2004 | US20040131598 Cancer therapy |
| 07/08/2004 | US20040131594 Malaria therapy; using pox virus vectors; genetic engineering; antitumor agents |
| 07/08/2004 | US20040131592 Gene expression of alphavirus; nucleotide sequences; induce immunology response; aids vaccine |
| 07/08/2004 | US20040131583 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/08/2004 | US20040131555 Mixture of tobramycin in carrier; aerosols; respiratory system disorders |
| 07/08/2004 | DE202004005959U1 Arzneimittel Drug |